Lv1
30 积分 2025-09-05 加入
DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma
1个月前
已完结
From heterogeneity to hope: emerging markers in triple-negative breast cancer research
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
3个月前
已完结
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
9个月前
已完结
Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom?
9个月前
已完结
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
9个月前
已完结
CD8-Guided Immunochemotherapy Improves Pathological Complete Response Rates in High Tumor Burden Triple-Negative Breast Cancer
10个月前
已完结
MTClin: Integrating MammaTyper® to Predict Neoadjuvant Therapy Response in HER2+ Breast Cancer
10个月前
已完结
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
1年前
已完结